REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 118 filers reported holding REVANCE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.88 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $532,000 | -70.3% | 19,293 | -71.6% | 0.03% | -72.7% |
| Q2 2017 | $1,794,000 | +21.1% | 67,961 | -4.6% | 0.12% | +19.8% |
| Q1 2017 | $1,482,000 | -3.6% | 71,241 | -4.0% | 0.10% | -10.6% |
| Q4 2016 | $1,537,000 | +16.5% | 74,217 | -8.8% | 0.11% | +15.3% |
| Q3 2016 | $1,319,000 | – | 81,369 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |